Market closed
Bioceres Crop Solutions/$BIOX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
Ticker
$BIOX
Sector
Trading on
Industry
Chemicals
Headquarters
Rosario, Argentina
Employees
-
BIOX Metrics
BasicAdvanced
$407M
Market cap
129.20
P/E ratio
$0.05
EPS
0.44
Beta
-
Dividend rate
Price and volume
Market cap
$407M
Beta
0.44
52-week high
$14.05
52-week low
$6.30
Average daily volume
165K
Financial strength
Current ratio
1.282
Quick ratio
0.906
Long term debt to equity
37.497
Total debt to equity
77.51
Interest coverage (TTM)
2.78%
Management effectiveness
Return on assets (TTM)
3.02%
Return on equity (TTM)
1.83%
Valuation
Price to earnings (TTM)
129.197
Price to revenue (TTM)
0.876
Price to book
1.3
Price to tangible book (TTM)
15.02
Price to free cash flow (TTM)
21.506
Growth
Revenue change (TTM)
10.81%
Earnings per share change (TTM)
-83.12%
3-year revenue growth (CAGR)
31.01%
3-year earnings per share growth (CAGR)
-34.09%
What the Analysts think about BIOX
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Bioceres Crop Solutions stock.
BIOX Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
BIOX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
BIOX News
AllArticlesVideos
Bioceres Is Getting Cheaper, Not Yet An Opportunity But More Interesting
Seeking Alpha·8 hours ago
Bioceres Crop Solutions Corp. (BIOX) Q1 2025 Earnings Call Transcript
Seeking Alpha·18 hours ago
Bioceres Crop Solutions Reports Fiscal First Quarter 2025 Financial and Operational Results
Business Wire·1 day ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Bioceres Crop Solutions stock?
Bioceres Crop Solutions (BIOX) has a market cap of $407M as of November 13, 2024.
What is the P/E ratio for Bioceres Crop Solutions stock?
The price to earnings (P/E) ratio for Bioceres Crop Solutions (BIOX) stock is 129.2 as of November 13, 2024.
Does Bioceres Crop Solutions stock pay dividends?
No, Bioceres Crop Solutions (BIOX) stock does not pay dividends to its shareholders as of November 13, 2024.
When is the next Bioceres Crop Solutions dividend payment date?
Bioceres Crop Solutions (BIOX) stock does not pay dividends to its shareholders.
What is the beta indicator for Bioceres Crop Solutions?
Bioceres Crop Solutions (BIOX) has a beta rating of 0.44. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.